Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells
- PMID: 12373454
- DOI: 10.1007/s00204-002-0381-3
Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells
Abstract
The metabolism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) has recently been implicated in the mechanisms underlying ecstasy-induced neurotoxicity and hepatotoxicity. However, its potential role in ecstasy-induced kidney toxicity has yet to be investigated. Thus, primary cultures of rat and human renal proximal tubular cells (PTCs) were used to investigate the cytotoxicity induced by MDMA and its metabolites methylenedioxyamphetamine (MDA), alpha-methyldopamine (alpha-MeDA), and the glutathione (GSH) conjugates 5-(glutathion- S-yl)-alpha-MeDA and 2,5- bis(glutathion- S-yl)-alpha-MeDA. Cell viability was evaluated using the mitochondrial MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. MDMA and MDA were not found to be toxic to either rat or human PTCs at any concentration tested (100-800 micro M). In contrast, 800 micro M alpha-MeDA caused 60% and 40% cell death in rat and human PTCs, respectively. Conjugation of alpha-MeDA with GSH resulted in the formation of even more potent nephrotoxicants. Thus, exposure of rat and human PTC monolayers to 400 micro M 5-(glutathion- S-yl)-alpha-MeDA caused approximately 80% and 70% cell death, respectively. 5-(Glutathion- S-yl)-alpha-MeDA (400 micro M) was more toxic than 2,5- bis(glutathion- S-yl)-alpha-MeDA to rat renal PTCs but equally potent in human renal PTCs. Pre-incubation of rat PTCs with either acivicin, an inhibitor of gamma-glutamyl transpeptidase (gamma-GT), or bestatin, an inhibitor of aminopeptidase M, resulted in increased toxicity of 5-(glutathion- S-yl)-alpha-MeDA but had no effect on 2,5- bis(glutathion- S-yl)-alpha-MeDA-mediated cytotoxicity. The present data provide evidence that metabolism is required for the expression of MDMA-induced renal toxicity in vitro. In addition, metabolism of 5-(glutathion- S-yl)-alpha-MeDA by gamma-GT and aminopeptidase M to the corresponding cystein- S-yl-glycine and/or cystein- S-yl conjugates is likely to be associated with detoxication of this compound. Thus, it appears that toxicity induced by thioether metabolites of ecstasy at the apical membrane of renal proximal tubular cells is the result of extracellular events, presumably redox cycling.
Similar articles
-
Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates.Arch Toxicol. 2004 Jan;78(1):16-24. doi: 10.1007/s00204-003-0510-7. Epub 2003 Oct 28. Arch Toxicol. 2004. PMID: 14586543
-
Neurotoxicity mechanisms of thioether ecstasy metabolites.Neuroscience. 2007 Jun 8;146(4):1743-57. doi: 10.1016/j.neuroscience.2007.03.028. Epub 2007 Apr 30. Neuroscience. 2007. PMID: 17467183
-
The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine.Toxicology. 2004 Aug 5;200(2-3):193-203. doi: 10.1016/j.tox.2004.03.016. Toxicology. 2004. PMID: 15212815
-
The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity.Ther Drug Monit. 2004 Apr;26(2):132-6. doi: 10.1097/00007691-200404000-00008. Ther Drug Monit. 2004. PMID: 15228153 Review.
-
Modulation of quinol/quinone-thioether toxicity by intramolecular detoxication.Drug Metab Rev. 1995;27(1-2):93-106. doi: 10.3109/03602539509029817. Drug Metab Rev. 1995. PMID: 7641587 Review.
Cited by
-
Acute toxic kidney injury.Ren Fail. 2019 Nov;41(1):576-594. doi: 10.1080/0886022X.2019.1628780. Ren Fail. 2019. PMID: 31237170 Free PMC article. Review.
-
Ecstasy produces left ventricular dysfunction and oxidative stress in rats.Cardiovasc Res. 2008 Sep 1;79(4):662-70. doi: 10.1093/cvr/cvn129. Epub 2008 May 20. Cardiovasc Res. 2008. PMID: 18495670 Free PMC article.
-
Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.Curr Pharm Biotechnol. 2010 Aug;11(5):434-43. doi: 10.2174/138920110791591436. Curr Pharm Biotechnol. 2010. PMID: 20420575 Free PMC article. Review.
-
Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.Mol Neurobiol. 2009 Jun;39(3):210-71. doi: 10.1007/s12035-009-8064-1. Epub 2009 Apr 17. Mol Neurobiol. 2009. PMID: 19373443 Review.
-
Time-Dependent Molecular Changes Following MDMA-Induced Nephrotoxicity.Iran J Pharm Res. 2024 May 18;23(1):e145483. doi: 10.5812/ijpr-145483. eCollection 2024 Jan-Dec. Iran J Pharm Res. 2024. PMID: 39830664 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous